Evidence map›Paper›PMID 39694574›Full record

ArticleOpen heart2024

Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements.

Rachel Si-Wen Chang, I-Min Chiu, Phillip Tacon, Michael Abiragi, Louie Cao, Gloria Hong, Jonathan Le, James Zou, Chathuri Daluwatte, Piero Ricchiuto and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Open heart, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07529860 (AI-based Echocardiography for Detection of Cardiac Amyloidosis in Patients Undergoing Transthoracic Echocardiography With Left Ventricular Hypertrophy), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07529860 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

AI-based Echocardiography for Detection of Cardiac Amyloidosis in Patients Undergoing Transthoracic Echocardiography With Left Ventricular Hypertrophy

TypeinterventionalSponsorGermans Trias i Pujol HospitalRan2026 to 2028Enrolled200ConditionsCardiac Amyloidosis, Heart Failure With Preserved Ejection Fraction (HFPEF), Left Ventricular HypertrophyArmsAI-based echocardiogram
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rachel Si-Wen ChangUCSF, San Francisco, California, USA.ORCID 0000-0002-8969-2757
I-Min ChiuCedars-Sinai Medical Center, Los Angeles, California, USA.
Phillip TaconCedars-Sinai Medical Center, Los Angeles, California, USA.
Michael AbiragiCedars-Sinai Medical Center, Los Angeles, California, USA.
Louie CaoCedars-Sinai Medical Center, Los Angeles, California, USA.
Gloria HongCedars-Sinai Medical Center, Los Angeles, California, USA.
Jonathan LeCedars-Sinai Medical Center, Los Angeles, California, USA.
James ZouStanford University, Stanford, California, USA.
Chathuri DaluwatteAlexion Pharmaceuticals, Boston, Massachusetts, USA.
Piero RicchiutoAlexion Pharmaceuticals, Boston, Massachusetts, USA.
David OuyangCedars-Sinai Medical Center, Los Angeles, California, USA david.ouyang@cshs.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.

objectivesOur objectives were to test a random forest (RF) model in detecting CA.

methodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.

resultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.

conclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.

Indexed as

AmyloidosisCardiomyopathiesEchocardiographyMachine LearningAgedFemaleHumansMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsRetrospective StudiesCardiomyopathy, RestrictiveDiagnostic ImagingEchocardiography

Identifiers

PMID39694574
PMCPMC11667434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.